Is Two Better Than One? Combination Therapy With Vedolizumab and Tofacitinib for the Treatment of Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Scheinberg, Andrew R. [1 ]
Dauer, Ryan M. [1 ]
Damas, Oriana M. [1 ]
Deshpande, Amar [1 ]
Abreu, Maria T. [1 ]
Kerman, David H. [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0895
引用
收藏
页码：S461 / S461
页数：1
相关论文
共 50 条
  • [1] Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease
    Llano, Ernesto M.
    Shrestha, Shreeju
    Burstein, Ezra
    Boktor, Moheb
    Fudman, David, I
    CROHNS & COLITIS 360, 2021, 3 (03)
  • [2] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [3] Evaluation of the Safety of Vedolizumab in Combination with Other Immunosuppression Biological Therapy in Patients with Inflammatory Bowel Disease
    Chesini, Gino
    Parrott, Elizabeth
    Fox, Lauren
    Beatty, Jenna
    Ken, Cassandra Eff
    Yu, Na
    Hosseini-Aslinia, Florence
    Krause, Megan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1953 - 1954
  • [4] Treatment Algorithm for Inflammatory Bowel Disease Patients Who Fail Vedolizumab as Salvage Therapy
    Cohen-Mekelburg, Shirley
    Ghosh, Gaurav
    Gold, Stephanie
    Schneider, Yecheskel
    Scherl, Ellen J.
    Steinlauf, Adam
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1479 - S1480
  • [5] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
    Christensen, Britt
    Gibson, Peter R.
    Micic, Dejan
    Colman, Ruben J.
    Goeppinger, Sarah R.
    Kassim, Olufemi
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 486 - 493
  • [6] Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
    Lutz, Megan
    Caldera, Freddy
    Schroeder, Katie
    Gazis, Derek
    Crawford, Julie M.
    Long, Millie D.
    Barnes, Edward L.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (11)
  • [7] Long-Term Outcomes of Treatment With and De-Escalation From a Combination of Vedolizumab and Another Biologic or Tofacitinib for Inflammatory Bowel Disease
    Jan, Jenny
    Fudman, David I.
    Llano, Ernesto M.
    Shrestha, Shreeju
    Burstein, Ezra
    Boktor, Moheb
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S737 - S738
  • [8] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [9] A combination therapy of Phages and Antibiotics: Two is better than one
    Li, Xianghui
    He, Yuhua
    Wang, Zhili
    Wei, Jiacun
    Hu, Tongxin
    Si, Jiangzhe
    Tao, Guangzhao
    Zhang, Lei
    Xie, Longxiang
    Abdalla, Abualgasim Elgaili
    Wang, Guoying
    Li, Yanzhang
    Teng, Tieshan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (13): : 3573 - 3582
  • [10] Two is better than one? Combination therapy in rheumatoid arthritis
    Choy, EH
    RHEUMATOLOGY, 2004, 43 (10) : 1205 - 1207
12345